Most organizations believe they are innovating. And in a narrow sense, they are — refining existing products, improving operational efficiency, incrementally extending what already works. The problem is that this kind of innovation, pursued almost exclusively, creates a specific and predictable vulnerability: competitors develop entirely new models while incumbents optimize the old ones.
The Innovation Ambition Matrix — introduced by Bansi Nagji and Geoff Tuff in the Harvard Business Review in 2012 — is one of the most useful tools available for diagnosing, and correcting, exactly this pattern.
What the Ambition Matrix Actually Does
The Innovation Ambition Matrix maps innovation initiatives across two dimensions: the newness of the product or offer (from existing to new, on the horizontal axis) and the newness of the market being served (from existing to new, on the vertical axis). The resulting space is divided into three zones — not quadrants — that represent meaningfully different types of innovation ambition:
- Core — incremental improvements to existing products for existing customers; optimizing what already works
- Adjacent — expanding from the current business into new but related territory; new offerings for existing customers, or existing offerings for new customer segments
- Transformational — breakthrough innovations targeting markets that don’t yet exist, or that require entirely new capabilities to serve
What makes the framework practically powerful is Nagji and Tuff’s research-backed finding on resource allocation. Companies that outperform their competitors tend to invest approximately 70% of innovation resources in Core, 20% in Adjacent, and 10% in Transformational initiatives. It’s not an equal split — and that’s the point. The ratio reflects the different risk profiles, time horizons, and return expectations across the three zones.
The Competitiveness Paradox
The most common portfolio failure pattern in enterprise organizations is an even heavier concentration in Core than the recommended 70% — often 90% or more — leaving Adjacent and Transformational initiatives chronically underfunded or existing only on paper.
These Core investments are individually defensible. They’re manageable, measurable, and generate near-term returns. They’re also the natural gravitational pull of any organization with quarterly performance pressures and established processes built around existing products and markets.
The structural problem is what happens in the aggregate. While an organization concentrates investment on optimizing its current model, competitors — often smaller and less encumbered — are building the Adjacent and Transformational capabilities that will define the next competitive landscape. By the time those initiatives mature into genuine market threats, the incumbent’s window to respond has often narrowed considerably.
Kodak optimized film while digital photography matured elsewhere. Blockbuster refined store operations while streaming infrastructure developed. The pattern is well-documented — and still remarkably common — precisely because the short-term logic of Core investment is always compelling.
Using the Matrix to Guide Resource Allocation
The practical value of the Ambition Matrix isn’t in labelling initiatives — it’s in making the aggregate portfolio visible, then asking honest questions about whether the distribution reflects deliberate strategic choices or default organizational behaviour.
A few diagnostic questions worth applying to any innovation portfolio in 2022:
- Is the Transformational allocation genuinely funded or aspirationally labelled? Many organizations claim Transformational initiatives but fund them at Core levels, producing neither the operational returns of focused Core investment nor the exploratory value of genuine Transformational bets
- Are the zone placements honest? Initiatives frequently migrate toward Core on the matrix because Core governance processes are the most mature — not because the initiative is genuinely incremental
- Is the portfolio being actively managed or passively accumulated? A healthy innovation portfolio requires regular review — moving initiatives between zones, accelerating some, stopping others — not simply adding new ones each quarter
The discipline of active portfolio management is, in many organizations, the missing ingredient. The framework exists. The categorization happens. The ongoing management of aggregate allocation against strategic intent is where the gap most often appears.
A Note for Founders on Enterprise Portfolio Positioning
For founders selling into enterprise organizations, the Ambition Matrix offers a genuinely useful lens for framing a product conversation. Enterprise buyers are managing innovation portfolios whether they use that language or not — and the most effective founders understand where their solution sits in that portfolio before walking into the room.
The positioning question worth working through: Is the product a Core play — reducing cost or improving efficiency in existing operations? An Adjacent play — enabling the customer to serve a new segment or enter a related market? Or a Transformational bet — creating entirely new capabilities the customer hasn’t yet operationalized?
Each answer calls for a different stakeholder, a different success metric, and a different conversation. A Core efficiency pitch to an innovation leader lands poorly. A Transformational conversation with a procurement manager goes nowhere. Getting the portfolio positioning right before the first meeting is one of the more underrated elements of enterprise go-to-market strategy.
How does your organization’s innovation portfolio actually look when mapped against the Ambition Matrix — and how much of that distribution is deliberate versus default? The 70-20-10 benchmark is a useful starting point. Where does your reality sit against it? Let’s keep learning — together.
harish.balasubramanian 
Share your thoughts